KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Retained Earnings: 2018-2025

Historic Retained Earnings for Adaptive Biotechnologies (ADPT) over the last 7 years, with Sep 2025 value amounting to -$1.3 billion.

  • Adaptive Biotechnologies' Retained Earnings fell 6.27% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 6.27%. This contributed to the annual value of -$1.3 billion for FY2024, which is 13.94% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Retained Earnings stood at -$1.3 billion, which was up 0.70% from -$1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Retained Earnings peaked at -$552.3 million during Q1 2021, and registered a low of -$1.4 billion during Q2 2025.
  • For the 3-year period, Adaptive Biotechnologies' Retained Earnings averaged around -$1.2 billion, with its median value being -$1.2 billion (2024).
  • Data for Adaptive Biotechnologies' Retained Earnings shows a maximum YoY slumped of 41.53% (in 2022) over the last 5 years.
  • Adaptive Biotechnologies' Retained Earnings (Quarterly) stood at -$718.9 million in 2021, then declined by 27.85% to -$919.1 million in 2022, then fell by 24.51% to -$1.1 billion in 2023, then fell by 13.94% to -$1.3 billion in 2024, then dropped by 6.27% to -$1.3 billion in 2025.
  • Its last three reported values are -$1.3 billion in Q3 2025, -$1.4 billion for Q2 2025, and -$1.3 billion during Q1 2025.